<DOC>
	<DOCNO>NCT02633644</DOCNO>
	<brief_summary>The purpose ENDO-HF study determine safety &amp; performance Harmony System treatment heart failure</brief_summary>
	<brief_title>Endovascular NeuromoDulation Treatment fOr Heart Failure Patients ( ENDO-HF )</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Subject diagnose chronic heart failure NYHA class IIIII Subject receive optimal medical treatment Subject sign date informed consent Subject severe aortic sclerosis calcification Subject diagnose severe aortic valve disease Subject severe mitral stenosis Subject involve concurrent clinical investigation Subject cerebral vascular accident transient ischemic attack prior enrollment Subject diagnose Marfan Syndrome Subject moderate severe chronic obstructive lung disease Subject allergic iodine contrast medium Subject prior cardiac transplant heart transplant candidate Subject life expectancy le 12 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Heart Failure</keyword>
	<keyword>Cardiovascular Diseases</keyword>
	<keyword>Heart Diseases</keyword>
</DOC>